Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,153,549
-
Total 13F shares
-
401,072
-
Share change
-
+401,072
-
Total reported value
-
$481,285
-
Price per share
-
$1.20
-
Number of holders
-
17
-
Value change
-
+$481,286
-
Number of buys
-
17
Institutional Holders of AETHLON MEDICAL INC - Common Stock (AEMD) as of Q2 2025
As of 30 Jun 2025,
AETHLON MEDICAL INC - Common Stock (AEMD) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
401,072 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Ikarian Capital, LLC, BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, BlackRock, Inc., Tower Research Capital LLC (TRC), MORGAN STANLEY, RAYMOND JAMES FINANCIAL INC, and GROUP ONE TRADING LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.